Biotron Limited (ASX:BIT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0020
-0.0005 (-20.00%)
Sep 3, 2026, 9:59 AM AEST

Biotron Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.530.531.811.651.431.56
Revenue Growth
--71.00%10.24%14.94%-8.16%6.61%
Gross Profit
0.530.531.811.651.431.56
Operating Income
-1.56-1.56-0.34-3.51-3.61-2.78
Net Income
-1.52-1.52-0.32-3.44-3.49-2.78
Earnings Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.551.550.930.393.981.74
Total Debt
---0.010.050.08
Net Cash (Debt)
1.551.550.930.393.941.66
Net Cash Growth
-5.41%66.79%141.32%-90.20%136.70%-60.42%
Net Cash Per Share
0.000.000.000.000.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.78-1.78-0.57-3.57-3.29-2.44
Capital Expenditures
---0---
Free Cash Flow
-1.78-1.78-0.57-3.57-3.29-2.44
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-295.91%-295.91%-18.68%-213.12%-252.08%-178.32%
Pretax Margin
-288.72%-288.72%-17.57%-208.89%-244.03%-178.44%
Profit Margin
-288.72%-288.72%-17.57%-208.89%-244.03%-178.44%
FCF Margin
-337.86%-337.86%-31.37%-216.92%-229.87%-156.31%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
10.5915.411.4620.8416.3827.47